15-LOX-1 Modulation of Colon Cancer Promotion by Linoleic Acid
亚油酸对 15-LOX-1 促进结肠癌的调节
基本信息
- 批准号:10330050
- 负责人:
- 金额:$ 1.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-01 至 2021-09-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Linoleic acid (LA) consumption is high in humans. LA increases azoxymethane (AOM)-induced colorectal tumorigenesis in rodents, but the impact of LA on colorectal cancer (CRC) in humans is unknown. 15- Lipoxygenase-1 (15-LOX-1) is the rate-limiting enzyme for the oxidative metabolism of LA to generate 13-S- HODE, a natural activating ligand of PPAR-gamma. PPAR-gamma suppresses aberrant Wnt/B-catenin signaling, a critical event initiating and driving CRC tumorigenesis. 15-LOX-1 is downregulated in human colorectal polyps and CRCs, but the influence of 15-LOX-1 on dietary LA modulation of CRC risk is unknown. In mice with intestinally targeted human 15-LOX-1 (15-LOX-1-Gut), we found that transgenic 15-LOX-1 expression suppressed CRC tumorigenesis, and 15-LOX-1 expression was downregulated in all experimentally-induced tumors. Furthermore, the increase in AOM-induced CRC with high LA dietary concentrations was repressed in 15-LOX-1-Gut mice; and 15-LOX-1 inhibited B-catenin activation. We therefore hypothesize that 15-LOX-1 loss in colonic epithelial cells is critical for excess LA to promote CRC tumorigenesis via augmenting Wnt/B-catenin signaling. We will test this hypothesis via 3 specific aims: Aims 1 and 2: Determine the effects of 15-LOX-1 expression (aim 1) and loss of expression (aim 2) in colonic epithelial cells on dietary LA promotion of CRC tumorigenesis and aberrant Wnt/B-catenin signaling. For aim 1, we will breed 15-LOX-1-Gut and Apc580mu mice to generate Apc580mu-15-LOX-1-Gut mice and examine the effects of 15-LOX-1 expression in mice fed high- or low-LA-content diets on CRC (tumor incidence and multiplicity), crypt proliferative zone length (Ki-67 IHC), activated B-catenin protein levels, and Wnt/B-catenin target gene (c-Myc, Cyclin D1, and Axin2) mRNA levels. For aim 2, we will replace 12-S-LOX in intestinal epithelial cells of 12/15-LOX knockout mice to generate mice with functional 15-LOX-1 loss and examine the effects in mice fed high- or low-LA-content diets on AOM-induced CRC, crypt proliferative zone length, and 13- HODE levels. We will also evaluate the effect of 15-LOX-1 gain of function (aim 1) and downregulation (aim 2) in human colonic cancerous and normal organoids (isolated from patients' colonic crypts) and cultured with various concentrations of LA on 13-HODE generation, cell proliferation, cell differentiation, and Wnt/B-catenin signaling. Aim 3: Determine the tempora and spatial effects of 15-LOX-1 expression in colonic epithelial cells on CRC tumorigenesis in relation to dietary LA intake. We will generate mice with conditional 15-LOX-1 expression, treat them with AOM, and feed them high- or low-LA-content diets. 15-LOX-1 expression will be induced during initiation or progression of CRC tumorigenesis, and we will examine the effects on the outcomes measured in aim 1. We expect these studies to provide important new information to direct development of novel interventions for CRC prevention and to identify subjects with low 15-LOX-1 expression as having increased risk of CRC tumorigenesis with high LA intake.
描述(由申请人提供):亚油酸(LA)在人体中的消耗量很高。LA增加了氧化偶氮甲烷(AOM)诱导的啮齿动物结直肠肿瘤发生,但LA对人类结直肠癌(CRC)的影响尚不清楚。15-脂氧合酶-1(15-LOX-1)是LA氧化代谢产生13-S-HODE(一种天然的PPAR-γ活化配体)的限速酶。PPAR-gamma抑制异常Wnt/B-连环蛋白信号传导,这是启动和驱动CRC肿瘤发生的关键事件。15-LOX-1在人类结直肠息肉和CRC中下调,但15-LOX-1对CRC风险的饮食LA调节的影响尚不清楚。在小鼠体内,我们发现转基因15-LOX-1表达抑制了CRC肿瘤的发生,并且在所有实验诱导的肿瘤中15-LOX-1表达下调。此外,在15-LOX-1-Gut小鼠中,用高LA饮食浓度的AOM诱导的CRC的增加被抑制;并且15-LOX-1抑制B-连环蛋白活化。因此,我们假设结肠上皮细胞中的15-LOX-1缺失对于过量LA通过增强Wnt/B-连环蛋白信号传导促进CRC肿瘤发生至关重要。我们将通过3个具体目的来检验这一假设:目的1和2:确定结肠上皮细胞中15-LOX-1表达(目的1)和表达缺失(目的2)对饮食LA促进CRC肿瘤发生和异常Wnt/B-连环蛋白信号传导的影响。为了实现目标1,我们将饲养15-LOX-1-Gut和Apc 580 mu小鼠,以产生Apc 580 mu-15-LOX-1-Gut小鼠,并检查喂食高或低LA含量饮食的小鼠中15-LOX-1表达对CRC的影响(肿瘤发生率和多样性),隐窝增殖区长度(Ki-67 IHC)、活化B-连环蛋白水平和Wnt/B-连环蛋白靶基因(c-Myc、细胞周期蛋白D1和Axin 2)mRNA水平。对于目标2,我们将替换12/15-LOX敲除小鼠的肠上皮细胞中的12-S-LOX以产生具有功能性15-LOX-1损失的小鼠,并检查喂食高或低LA含量饮食的小鼠对AOM诱导的CRC、隐窝增殖区长度和13- HODE水平的影响。我们还将评估15-LOX-1在人结肠癌性和正常类器官(从患者的结肠隐窝分离)中的功能获得(目的1)和下调(目的2)并与各种浓度的LA一起培养对13-HODE产生、细胞增殖、细胞分化和Wnt/B-连环蛋白信号传导的影响。目标3:确定结肠上皮细胞中15-LOX-1表达对CRC肿瘤发生的时间和空间效应与饮食LA摄入量的关系。我们将产生具有条件性15-LOX-1表达的小鼠,用AOM治疗它们,并给它们喂食高或低LA含量的饮食。15-LOX-1表达将在CRC肿瘤发生的开始或进展期间被诱导,并且我们将检查对目标1中测量的结果的影响。我们预计这些研究将提供重要的新信息,以指导开发预防CRC的新型干预措施,并确定15-LOX-1表达低的受试者在摄入高LA的情况下患CRC肿瘤的风险增加。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Suppression of Membranous LRP5 Recycling, Wnt/β-Catenin Signaling, and Colon Carcinogenesis by 15-LOX-1 Peroxidation of Linoleic Acid in PI3P.
- DOI:10.1016/j.celrep.2020.108049
- 发表时间:2020-08-18
- 期刊:
- 影响因子:8.8
- 作者:Liu F;Zuo X;Liu Y;Deguchi Y;Moussalli MJ;Chen W;Yang P;Wei B;Tan L;Lorenzi PL;Gao S;Jaoude JC;Mehdizadeh A;Valentin LA;Wei D;Shureiqi I
- 通讯作者:Shureiqi I
The Role of PPAR-δ in Metabolism, Inflammation, and Cancer: Many Characters of a Critical Transcription Factor.
- DOI:10.3390/ijms19113339
- 发表时间:2018-10-26
- 期刊:
- 影响因子:5.6
- 作者:Liu Y;Colby JK;Zuo X;Jaoude J;Wei D;Shureiqi I
- 通讯作者:Shureiqi I
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Imad Shureiqi其他文献
Imad Shureiqi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Imad Shureiqi', 18)}}的其他基金
ALOX15 regulation of colon cancer invasiveness via PI3P-linoleic acid metabolism
ALOX15 通过 PI3P-亚油酸代谢调节结肠癌侵袭力
- 批准号:
10339182 - 财政年份:2022
- 资助金额:
$ 1.31万 - 项目类别:
ALOX15 regulation of colon cancer invasiveness via PI3P-linoleic acid metabolism
ALOX15 通过 PI3P-亚油酸代谢调节结肠癌侵袭性
- 批准号:
10545078 - 财政年份:2022
- 资助金额:
$ 1.31万 - 项目类别:
15-LOX-1 regulation of resolving generation to modulate colon cancer
15-LOX-1 调节分解生成以调节结肠癌
- 批准号:
10301423 - 财政年份:2016
- 资助金额:
$ 1.31万 - 项目类别:
15-LOX-1 Regulation of Resolving Generation to Modulate Colon Cancer
15-LOX-1 调节分解生成以调节结肠癌
- 批准号:
9980183 - 财政年份:2016
- 资助金额:
$ 1.31万 - 项目类别:
15-LOX-1 Modulation of Colon Cancer Promotion by Linoleic Acid
亚油酸对 15-LOX-1 促进结肠癌的调节
- 批准号:
9886073 - 财政年份:2016
- 资助金额:
$ 1.31万 - 项目类别:
15-LOX-1 Regulation of Resolving Generation to Modulate Colon Cancer
15-LOX-1 调节分解生成以调节结肠癌
- 批准号:
9187612 - 财政年份:2016
- 资助金额:
$ 1.31万 - 项目类别:
Molecular targeting of PPAR-delta in colon cancer
结肠癌中 PPAR-δ 的分子靶向
- 批准号:
7987654 - 财政年份:2010
- 资助金额:
$ 1.31万 - 项目类别:
Molecular targeting of PPAR-delta in colon cancer
结肠癌中 PPAR-δ 的分子靶向
- 批准号:
8259197 - 财政年份:2010
- 资助金额:
$ 1.31万 - 项目类别:
Molecular targeting of PPAR-delta in colon cancer
结肠癌中 PPAR-δ 的分子靶向
- 批准号:
8091356 - 财政年份:2010
- 资助金额:
$ 1.31万 - 项目类别:
Molecular targeting of PPAR-delta in colon cancer
结肠癌中 PPAR-δ 的分子靶向
- 批准号:
8657861 - 财政年份:2010
- 资助金额:
$ 1.31万 - 项目类别:
相似国自然基金
基于线粒体损伤—铁死亡途径探讨电针心包经穴调控ACSL4/LPCAT3/LOX信号通路抑制脂质过氧化对MCAO大鼠的脑保护机制
- 批准号:2025JJ90016
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
Lox介导神经元-星形胶质细胞对话在颞叶癫痫中的作用机制及药物干预研究
- 批准号:2025JJ20087
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
LOX-1介导肺栓塞形成及分子机制研究
- 批准号:2025JJ80193
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
CAF来源LOX对胃癌肿瘤干细胞组蛋白乳酰化调控作用的机制研究
- 批准号:2025JJ60596
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
从 miR-181b-3p 双靶向 15-LOX/FPRL1 调控炎症消退探讨
清热利湿法治疗盆腔炎的作用
- 批准号:2024JJ8148
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
Xiap 通过增强 5-LOX介导的花生四烯酸代谢保护结直肠癌细胞免受铁死亡影响从而降低抗 PD-1 疗效
- 批准号:
- 批准年份:2024
- 资助金额:10.0 万元
- 项目类别:省市级项目
具有抗炎和力学恢复功能的LOX@GelMA水凝胶在椎间盘退变修复中的应用研究
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于“脾统血濡脉”探讨健脾益气法调控LOX-1/SPP1/EGF通路驱动mtROS 预防AS分子机制研究
- 批准号:82305061
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
LOX-1介导GLS1琥珀酰化调控谷氨酰胺代谢重编程促进非酒精性脂肪性肝病的作用和机制研究
- 批准号:2023JJ20081
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
单核细胞通过THBS1-SDC4-MAPK信号轴激活Lox高表达成纤维细胞亚群并促进辐射诱导肺纤维化的机制研究
- 批准号:82304069
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
新生児低酸素性虚血性脳症における、LOX-1をターゲットとした新規治療法の開発
开发针对新生儿缺氧缺血性脑病的LOX-1新疗法
- 批准号:
24K18861 - 财政年份:2024
- 资助金额:
$ 1.31万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Cell-free hemoglobin-oxidized LDL-LOX-1 axis and microvascular hyperpermeability during sepsis
脓毒症期间无细胞血红蛋白氧化的 LDL-LOX-1 轴和微血管通透性过高
- 批准号:
10739620 - 财政年份:2023
- 资助金额:
$ 1.31万 - 项目类别:
Targeting LOX-1 for MDSC-inhibition therapy against cervical cancer
以 LOX-1 为靶点进行 MDSC 抑制治疗宫颈癌
- 批准号:
23K06666 - 财政年份:2023
- 资助金额:
$ 1.31万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
LOX-1 as a protective countermeasure in response to lung infection
LOX-1 作为应对肺部感染的保护性对策
- 批准号:
10677924 - 财政年份:2023
- 资助金额:
$ 1.31万 - 项目类别:
Generation and characterization of a Cre-Lox regulated transgenic zebrafish model of SBMA
Cre-Lox 调节的 SBMA 转基因斑马鱼模型的生成和表征
- 批准号:
10784254 - 财政年份:2023
- 资助金额:
$ 1.31万 - 项目类别:
SBIR Phase II: Liquid Oxygen (LOX) - Methane Engine for Small Satellite Launch Vehicles
SBIR 第二阶段:液氧 (LOX) - 小型卫星运载火箭的甲烷发动机
- 批准号:
2303613 - 财政年份:2023
- 资助金额:
$ 1.31万 - 项目类别:
Cooperative Agreement
Developing novel LOX inhibitors to target chemotherapy resistant TNBC
开发新型 LOX 抑制剂以靶向化疗耐药的 TNBC
- 批准号:
10696810 - 财政年份:2023
- 资助金额:
$ 1.31万 - 项目类别:
Establishing Mechanisms of LOX-1-Dependent Immune Regulation During Pneumonia
建立肺炎期间LOX-1依赖性免疫调节机制
- 批准号:
10526202 - 财政年份:2022
- 资助金额:
$ 1.31万 - 项目类别:
LOX-1 as a protective countermeasure in response to lung infection
LOX-1 作为应对肺部感染的保护性对策
- 批准号:
10690260 - 财政年份:2022
- 资助金额:
$ 1.31万 - 项目类别:
Establishing Mechanisms of LOX-1-Dependent Immune Regulation During Pneumonia
建立肺炎期间LOX-1依赖性免疫调节机制
- 批准号:
10674622 - 财政年份:2022
- 资助金额:
$ 1.31万 - 项目类别:














{{item.name}}会员




